AAAAAA

   
Results: 1-8 |
Results: 8
Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade
Authors: Cartmell, J Perry, KW Salhoff, CR Monn, JA Schoepp, DD
Citation: J. Cartmell et al., Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade, NEUROPHARM, 40(7), 2001, pp. 847-855
Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine
Authors: Cartmell, J Monn, JA Schoepp, DD
Citation: J. Cartmell et al., Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine, PSYCHOPHAR, 148(4), 2000, pp. 423-429
Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268
Authors: Cartmell, J Monn, JA Schoepp, DD
Citation: J. Cartmell et al., Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268, N-S ARCH PH, 361(1), 2000, pp. 39-46
Regulation of neurotransmitter release by metabotropic glutamate receptors
Authors: Cartmell, J Schoepp, DD
Citation: J. Cartmell et Dd. Schoepp, Regulation of neurotransmitter release by metabotropic glutamate receptors, J NEUROCHEM, 75(3), 2000, pp. 889-907
The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat
Authors: Cartmell, J Perry, KW Salhoff, CR Monn, JA Schoepp, DD
Citation: J. Cartmell et al., The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat, J NEUROCHEM, 75(3), 2000, pp. 1147-1154
The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing
Authors: Cartmell, J Monn, JA Schoepp, DD
Citation: J. Cartmell et al., The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing, EUR J PHARM, 400(2-3), 2000, pp. 221-224
Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum
Authors: Cartmell, J Salhoff, CR Perry, KW Monn, JA Schoepp, DD
Citation: J. Cartmell et al., Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum, BRAIN RES, 887(2), 2000, pp. 378-384
The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats
Authors: Cartmell, J Monn, JA Schoepp, DD
Citation: J. Cartmell et al., The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats, J PHARM EXP, 291(1), 1999, pp. 161-170
Risultati: 1-8 |